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Julie A Pasco1,2*, Kara L Holloway1, Amelia G Dobbins1, Mark A Kotowicz1,2, Lana J Williams1 and Sharon L Brennan1,2Abstract
Background: The body mass index (BMI) is commonly used as a surrogate marker for adiposity. However, the BMI
indicates weight-for-height without considering differences in body composition and the contribution of body fat
to overall body weight.
The aim of this cross-sectional study was to identify sex-and-age-specific values for percentage body fat (%BF),
measured using whole body dual energy x-ray absorptiometry (DXA), that correspond to BMI 18.5 kg/m2 (threshold
for underweight), 25.0 kg/m2 (overweight) and 30.0 kg/m2 (obesity) and compare the prevalence of underweight,
overweight and obesity in the adult white Australian population using these BMI thresholds and equivalent values
for %BF. These analyses utilise data from randomly-selected men (n = 1446) and women (n = 1045), age 20–96 years,
who had concurrent anthropometry and DXA assessments as part of the Geelong Osteoporosis Study, 2001–2008.
Results: Values for %BF cut-points for underweight, overweight and obesity were predicted from sex, age and BMI.
Using these cut-points, the age-standardised prevalence among men for underweight was 3.1% (95% CI 2.1, 4.1),
overweight 40.4% (95% CI 37.7, 43.1) and obesity 24.7% (95% CI 22.2, 27.1); among women, prevalence for
underweight was 3.8% (95% CI 2.6, 5.0), overweight 32.3% (95% CI 29.5, 35.2) and obesity 29.5% (95% CI 26.7,
32.3). Prevalence estimates using BMI criteria for men were: underweight 0.6% (95% CI 0.2, 1.1), overweight
45.5% (95% CI 42.7, 48.2) and obesity 19.7% (95% CI 17.5, 21.9); and for women, underweight 1.4% (95% CI 0.7, 2.0),
overweight 30.3% (95% CI 27.5, 33.1) and obesity 28.2% (95% CI 25.4, 31.0).
Conclusions: Utilising a single BMI threshold may underestimate the true extent of obesity in the white population,
particularly among men. Similarly, the BMI underestimates the prevalence of underweight, suggesting that this body
build is apparent in the population, albeit at a low prevalence. Optimal thresholds for defining underweight and
obesity will ultimately depend on risk assessment for impaired health and early mortality.
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Globally, obesity has nearly doubled over the last three
decades [1]. In Australia, the prevalence of obesity among
adults has increased from 11.1% in 1995 to 16.4% in
2004–05 [2] and this upward trend is predicted to
continue over coming decades [3]. Global and local
prevalence estimates are based on the body mass
index (BMI) which provide a guide to obesity levels as* Correspondence: juliep@barwonhealth.org.au
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unless otherwise stated.recognised by BMI values greater than or equal to 30. Yet
the BMI is a ratio of body weight-for-height [4] thereby
limiting its usefulness as an indicator for adiposity because
no account is made of variations in body composition.
Clear shortcomings are evident when the BMI overesti-
mates adiposity in muscular body builds and underesti-
mates adiposity in the elderly [5,6].
The simplicity and ease of measurement have entrenched
the widespread use of the BMI as a marker of adiposity,
not only for epidemiological purposes, but also in clinical
practice. The aim of this study was to measure body fat
mass using whole body dual energy x-ray absorptiometry
(DXA) and BMI in a population-based sample of men andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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percentage body fat (%BF) that correspond to internation-
ally recognised BMI cut-points for defining underweight,
overweight and obesity. This approach extends previous
studies that utilised %BF thresholds of 25% for men and
35% for obesity [6,7]. We have previously reported a
temporal shift in the distribution of BMI in the popula-
tion such that the prevalence of underweight women
diminished between 1993–1997 and 2004–2007 [8], but
that study did not investigate changes in body compos-
ition. The aim of this study was to compare prevalence
estimates for underweight, overweight and obesity in the
adult white Australian population using BMI thresholds
for each category and the equivalent sex-and-age-specific
cut-points for %BF.
Methods
Ethics statement
The study was approved by the Barwon Health Human
Research Ethics Committee. All participants provided
informed, written consent.
Subjects
This cross-sectional study was conducted as part of the
Geelong Osteoporosis Study (GOS), a population-based
cohort study, set in the Barwon Statistical Division in
south-eastern Australia [9]. Age-stratified samples of men
and women were selected at random from the Common-
wealth electoral roll, which provides an ideal sampling
frame for epidemiological research in Australia because
registration with the Australian Electoral Commission
is compulsory for residents aged 18 years and over. In
total, 1467 men were recruited 2001–2006 (67% participa-
tion, age 20–96 years) and 1494 women were recruited
1993–1997 (77% participation, age 20–93 years). This set
of analyses utilises data collected at the baseline visit for
1467 men, and the 10-year follow-up (2003–2008) for 882
women (82% retention of eligible women). A further 194
women aged 20–29 years were recruited 2005–2008 (82%
participation), providing a total sample 1076 women for
this analysis. The cohort was essentially white; no indi-
genous Australians participated in the study. Details of
participation and non-participation have been described
elsewhere [9,10].
Body composition measures
Body weight was measured to ± 0.1 kg using electronic
scales, standing height was measured to ± 0.001 m using
a wall mounted stadiometer and BMI was calculated
as weight/height2 (kg/m2). Based on WHO criteria
[11], underweight was identified as BMI < 18.5 kg/m2,
overweight as BMI 25.0-29.9 kg/m2, and obese as
BMI ≥ 30.0 kg/m2. Measures of body fat mass, lean
mass and bone mineral content were provided bywhole body DXA using a Lunar DPX-L densitometer
(software version 1.31; Lunar, Madison, WI, USA); how-
ever, 923 of the men were scanned on a GE-Lunar Prodigy
(Prodigy; GE Lunar, Madison, WI, USA) when the DPX-L
was decommissioned. No significant differences were de-
tected in lumbar spine or femoral neck bone mineral
density measurements when the scanners were cross cali-
brated on 40 subjects aged 21 to 82 years. The percentage
body fat (%BF) was calculated as body fat mass expressed
as a percentage of the sum of body fat mass, lean mass
and bone mineral content. Individuals without valid whole
body scans (21 men and 31 women) were excluded.
Anthropometry was performed by trained personnel and
the densitometer operators had completed the accredited
Australian and New Zealand Bone and Mineral Society
(ANZBMS) Clinical Densitometry Training Course and
were licenced through the Department of Health State
Government of Victoria to use radiation sources for
research.
Statistical analyses
The %BF values equivalent to the BMI cut-points 18.5,
25.0 and 30.0 kg/m2, which are used to identify under-
weight, overweight and obesity, respectively, were predicted
using the following equation [5].
%BF ¼ 37:8þ 1:62  BMI−mð Þ–0:06
 BMI−mð Þ2–16:7  sexþ 0:02  age–0:17
 sex  BMI−mð Þ þ 0:03  sex  BMI−mð Þ2
þ 0:04  sex  age
Variables include: sex (male = 1, female = 0), age (years)
and BMI (kg/m2) centred around the mean (26.4 kg/m2)
to reduce collinearity. The model includes interaction
terms between sex and BMI, and sex and age. The equa-
tion had been derived previously using a subset of 1299
men and 855 women from the Geelong Osteoporosis
Study for whom whole body DXA scans provided valid
measures of body fat mass. Details of the development
of this equation have been described elsewhere [5].
Individuals were classified as underweight, normal
weight, overweight or obese according to published
BMI cut-points and according to sex-and-age-specific
%BF cut-points. A kappa (κ) statistic indicated the
level of agreement between categories using the two
sets of criteria. Sex-stratified prevalence estimates for
underweight, overweight and obesity were determined
according to BMI thresholds and the corresponding
(calculated) %BF thresholds for age decades 20–79 years
and 80 years and older, using mid-decade ages of 25, 35,
45, 55, 65, 75 and 85 years. Overall prevalence estimates
were age-standardised to national age profiles using data
from the Australian Bureau of Statistics (ABS cat. no.
2068.0 – 2006 Census Tables). A sensitivity analysis that
Table 1 Mean sex-and-age-specific cut-points for
percentage body fat equivalent to body mass index
18.5 kg/m2 (underweight), 25.0 kg/m2 (overweight) and
BMI 30.0 kg/m2 (obese)
Age (yr) Underweight Overweight Obese
Men Women Men Women Men Women
20-29 9.3 21.8 20.6 36.0 27.5 43.4
30-39 9.9 22.0 21.2 36.2 28.1 43.6
40-49 10.5 22.2 21.8 36.4 28.7 43.8
50-59 11.1 22.4 22.4 36.6 29.3 44.0
60-69 11.7 22.6 23.0 36.8 29.9 44.2
70-79 12.3 22.8 23.6 37.0 30.5 44.4
80+ 12.9 23.0 24.2 37.2 31.1 44.6
BMI body mass index (kg/m2); %BF percentage body fat mass.
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BMI and %BF criteria was performed after excluding men
scanned on the DPX-L densitometer. Statistical analyses
were performed using Minitab (version 16, Minitab, State
College, PA, USA).
Results
%BF thresholds for underweight, overweight and obesity
Mean predicted sex-and-age-specific %BF values that are
equivalent to the BMI values of 18.5, 25.0 and 30.0 kg/m2
are shown in Table 1, where the data are stratified by sex
and age-group. The %BF thresholds increased with age
and were consistently lower for men than for women
across all age-groups. The sex-and-age-specific thresholds
for %BF were subsequently used to identify underweight,
normal weight, overweight and obese individuals.
Prevalence of underweight, overweight and obesity
Numbers of men and women in the categories of under-
weight, ideal weight, overweight and obese by age-group
are shown in Table 2. Mean BMI and %BF values for
men and women by age-group are listed in Table 3. MeanTable 2 Numbers of individuals in each BMI category (underw
sex and age
Age (yr) Underweight Ideal weight
Men Women Men Wom
20-29 2 4 111 103
30-39 2 1 76 73
40-49 0 2 61 63
50-59 0 1 42 54
60-69 2 2 43 46
70-79 2 2 59 37
80+ 3 3 67 27
All 11 15 459 403
BMI body mass index (kg/m2).
BMI categories: Underweight BMI < 18.5 kg/m2, ideal weight BMI 18.5-24.9 kg/m2, oprevalence estimates for underweight, overweight and
obesity according to BMI thresholds and sex-and-age-spe-
cific %BF thresholds, for men and women stratified by
age-group, are shown in Table 4 and presented graphically
for underweight and obesity in Figure 1. In women, both
methods indicated that the prevalence of obesity increased
with age until 50–59 years, followed by an age-related
decline. The age-related profile for men according to BMI
criteria showed an age-related increase that peaked at age
60–69 years followed by an age-related decline; however,
%BF values indicate that obesity was under-estimated in
younger men and elderly men than BMI would suggest.
For both sexes, the prevalence of overweight was similar
for both BMI and %BF criteria. The BMI tended to under-
estimate the prevalence of underweight in both sexes
particularly for young adults.
A sensitivity analysis that excluded men scanned on
the DPX-L densitometer showed that the age-related
patterns based on %BF criteria were sustained and, import-
antly, significant differences persisted between prevalence
estimates based on BMI and %BF criteria for the two age
groups 20–29 years and 80+ years obesity: prevalence for
age 20–29 years BMI 8.2% (95% CI 4.5, 13.4) and %BF
25.1% (95% CI 18.8, 32.3), and for age 80+ BMI 13.4% (95%
CI 8.7, 19.5) and %BF 29.8% (95% CI 23.1, 37.3).
According to age-specific %BF criteria for men, the
overall mean age-standardised prevalence for underweight
was 3.1% (95% CI 2.1, 4.1), overweight 40.4% (95% CI
37.7, 43.1) and obesity 24.7% (95% CI 22.2, 27.1). For
women, the prevalence for underweight was 3.8% (95% CI
2.6, 5.0), overweight 32.3% (95% CI 29.5, 35.2) and obesity
29.5% (95% CI 26.7, 32.3).
According to BMI criteria for men, the overall mean
age-standardised prevalence for underweight was 0.6%
(95% CI 0.2, 1.1), overweight 45.5% (95% CI 42.7, 48.2)
and obesity 19.7% (95% CI 17.5, 21.9). For women, the
prevalence for underweight was 1.4% (95% CI 0.7, 2.0),
overweight 30.3% (95% CI 27.5, 33.1) and obesity 28.2%eight, ideal weight, overweight and obese) stratified by
Overweight Obese
en Men Women Men Women
53 42 15 42
83 34 34 30
102 60 43 50
123 58 57 70
103 52 63 54
121 53 56 40
97 27 26 15
682 326 294 301
verweight BMI 25.0-29.9 kg/m2 and obese BMI ≥ 30.0 kg/m2.
Table 3 Mean (standard deviation) values for body mass
index and percentage body fat stratified by sex and age
Men Women
Age (yr) BMI %BF BMI %BF
20-29 24.6 (3.5) 20.8 (8.1) 26.2 (6.5) 36.1 (9.5)
30-39 26.3 (3.7) 22.8 (7.1) 26.5 (5.9) 36.7 (9.2)
40-49 27.3 (3.9) 24.2 (5.5) 27.7 (6.0) 38.7 (8.1)
50-59 28.0 (4.0) 25.8 (6.2) 29.0 (6.1) 41.3 (8.3)
60-69 27.2 (4.2) 26.7 (6.4) 28.0 (5.1) 40.5 (7.4)
70-79 27.3 (4.0) 26.9 (6.4) 27.9 (4.9) 40.9 (7.6)
80+ 26.1 (3.3) 27.1 (6.9) 26.4 (4.4) 38.4 (7.9)
BMI body mass index (kg/m2); %BF percentage body fat mass.
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prevalence for underweight for both men and women was
lower according to BMI. For men, the age-standardised
prevalence for obesity was similarly lower according to
BMI; for women the difference in estimates of age-
standardised prevalence for obesity based on BMI and %
BF was not significant. No differences were detected in
age-standardised prevalence estimates for overweight in
either sex.Agreement between categories based on BMI and
%BF criteria
There was exact agreement using sex-and-age-specific %BF
and BMI criteria for categorising underweight, ideal weight,
overweight and obese groups for 62.6% men (κ = 0.4) and
73.9% women (κ = 0.6); agreement to within one category
was observed for 98.7% men and 99.8% women. WhereasTable 4 Sex-and-age-stratified prevalence (mean percentage
and obesity determined by body mass index and sex-and-age
Age (yr) 20-29 30-39 40-49
Men n 181 195 206
BMI Underweight 1.1 (0.1, 3.9) 1.0 (0.1, 3.7) 0.0 (0.0, 1
Overweight 29.3 (22.8, 36.5) 42.6 (35.5, 49.8) 49.5 (42.5,
Obese 8.3 (4.7, 13.3) 17.4 (12.4, 23.5) 20.9 (15.5,
%BF Underweight 4.4 (1.9, 8.5) 6.2 (3.2, 10.5) 1.5 (0.3, 4
Overweight 22.7 (16.8, 29.4) 34.9 (28.2, 42.0) 51.5 (44.4,
Obese 24.3 (18.3, 31.2) 25.1 (19.2, 31.8) 18.9 (13.8,
Women n 191 138 175
BMI Underweight 2.1 (0.6, 5.3) 0.7 (0.0, 4.0) 1.1 (0.1, 4
Overweight 22.0 (16.3, 28.5) 24.6 (17.7, 32.7) 34.3 (27.3,
Obese 22.0 (16.3, 28.5) 21.7 (15.2, 29.6) 28.6 (22.0,
%BF Underweight 6.3 (3.3, 10.7) 5.8 (2.5, 11.1) 2.9 (0.9, 6
Overweight 23.6 (17.7, 30.2) 25.4 (18.3, 33.5) 34.9 (27.8,
Obese 25.7 (19.6, 32.5) 25.4 (18.3, 33.5) 29.1 (22.5,
BMI body mass index (kg/m2); %BF percentage body fat mass.82.7% of women classed as obese according to BMI were
also identified as obese according to sex-and-age-specific %
BF criteria, only 68.4% of men classed as obese by BMI
were similarly classified by sex-and-age-specific %BF. On
the other hand, 80.1% of women and 53.9% of men who
were identified as obese according to sex-and-age-specific
%BF criteria, had BMI ≥ 30.0 k/m2.
Discussion
Using sex-and-age-specific cut-points for %BF equivalent
to BMI 30.0 kg/m2, we report that 24.7% (95% CI 22.2,
27.1) of men and 29.5% (95% CI 26.7, 32.3) of women
were obese. The prevalence estimate for men was greater
than the estimate of 19.7% (95% CI 17.5, 21.9), which was
based on BMI criteria. The pattern was similar for women
for whom the prevalence of obesity according to the BMI
was 28.2% (95% CI 25.4, 31.0); however, the difference in
the estimates was not significant. For both sexes, the
prevalence of underweight was lower according to BMI.
Whereas three-quarters of the women were similarly clas-
sified into groupings ranging from underweight to obese
according to both %BF and BMI criteria, exact agreement
was observed for less than two-thirds of the men.
Our approach was similar to that reported by Gallagher
et al. [12] who derived %BF cut-points from several diag-
nostic techniques, including DXA, which corresponded to
the published BMI thresholds for underweight, overweight
and obesity. Prediction equations for %BF were evaluated
for adults (from BMI, sex, age and ethnicity) in order to
identify healthy %BF ranges. Similar techniques have been
employed by others in order to evaluate the validity of
the BMI threshold for obesity in different populationsand 95% confidence interval) of underweight, overweight
-specific percentage body fat mass criteria
50-59 60-69 70-79 80+
222 211 238 193
.4) 0.0 (0.0, 1.3) 0.9 (0.1, 3.4) 0.8 (0.1, 3.0) 1.6 (0.3, 4.5)
56.4) 55.4 (48.6, 62.1) 48.8 (41.9, 55.8) 50.8 (44.3, 57.4) 50.3 (43.0, 57.5)
27.1) 25.7 (20.1, 31.9) 29.9 (23.8, 36.5) 23.5 (18.3, 29.4) 13.5 (9.0, 19.1)
.2) 1.8 (0.5, 4.5) 2.4 (0.8, 5.4) 1.7 (0.5, 4.2) 2.1 (0.6, 5.2)
58.5) 49.5 (42.8, 56.3) 42.7 (35.9, 49.6) 44.1 (37.7, 50.7) 42.0 (34.9, 49.3)
25.0) 25.7 (20.1, 31.9) 28.9 (22.9, 35.5) 29.0 (23.3, 35.2) 28.0 (21.8, 34.9)
183 154 132 72
.1) 0.5 (0.0, 3.0) 1.3 (0.2, 4.6) 1.5 (0.2, 5.4) 4.2 (0.9, 11.7)
41.8) 31.7 (25.0, 39.0) 33.8 (26.4, 41.8) 40.2 (31.7, 49.0) 37.5 (26.4, 49.7)
35.9) 38.3 (31.2, 45.7) 35.1 (27.6, 43.2) 30.3 (22.6, 38.9) 20.8 (12.2, 32.0)
.5) 1.1 (0.1, 3.9) 1.3 (0.2, 4.6) 3.0 (0.8, 7.6) 6.9 (2.3, 15.5)
41.4) 35.0 (28.1, 42.4) 34.4 (27.0, 42.5) 53.0 (44.2, 61.8) 36.1 (25.1, 48.3)
36.5) 38.8 (31.7, 46.3) 33.1 (25.8, 41.1) 28.0 (20.6, 36.5) 23.6 (14.4, 35.1)
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Figure 1 Age-specific prevalence of obesity and underweight using body mass index and percentage body fat criteria. Age-specific
prevalence of obesity (solid lines and symbols) and underweight (broken lines and hollow symbols) defined using body mass index (BMI) thresholds
(grey lines and square symbols) and sex-and-age-specific percentage body fat (%BF) thresholds (black lines and circular symbols). Data are for (A) men
and (B) women by age decades (20 represents 20–29 years, etc.). Data are shown as mean and 95% confidence intervals.
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has utilised sex-and-age-specific %BF thresholds equivalent
to published BMI thresholds to compare prevalence
estimates of underweight, overweight and obesity.
Our results suggest that 17.3% of women and 31.6% of
men who were identified as obese according to BMI
were misclassified according to sex-and-age-specific %BF
criteria. The inability to distinguish the different contri-
butions to body weight, of fat and non-fat tissue (such
as muscle and bone, which have greater densities than
fat), explains why the BMI might overestimate adiposity
in muscular and lean body builds. On the other hand,
only 80.1% of women and 53.9% of men in our study who
were classified as obese using sex-and-age-specific %BF
thresholds had BMI in the obese range. As a corollary,
19.9% of women and 46.1% men with high %BF were
overlooked as being obese according to BMI criteria. TheBMI might underestimate adiposity as a consequence of
age-related lean tissue loss, particularly skeletal muscle,
and accumulation of fat; these are characteristics of sarco-
penic obesity seen in the elderly [15,16]. Results from our
study support the contention that BMI underestimates
adiposity in elderly men (aged 70 years and older). Para-
doxically, our study also suggests that the BMI markedly
underestimated adiposity in young men (aged 20–29
years). It seems likely that for this group, body fat contrib-
utes more, and lean tissue less, to body weight than in
other groups. While the reasons for this remain unclear,
we might speculate that the fat-to-lean tissue mass ratio is
disproportionately high as a result of unhealthy lifestyle
choices including sedentary behaviour and poor nutrition.
Differences in body composition might also be related to
an increasing prevalence of growth hormone deficiency
with increasing age, resulting in loss of lean tissue and
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health implications, as the prevalence of adult obesity
as described by the BMI, may be underestimated at a
population level, particularly among men.
Both the BMI and %BF identify weight or fat mass
relative to the whole body, but this has been conceptual-
ized differently for the two indices. The BMI expresses
body weight (kg) relative to stature (height, m2) and it
should be noted that adjustment for height in this index is
suboptimal [18]. The second order polynomial relation-
ship between BMI and %BF [5] is partly explained by the
relative relationship of body fat mass to total body weight;
increments in body fat mass result in diminishing incre-
ments in %BF. Furthermore, accumulation of body fat in
healthy bodies is generally accompanied by a compensa-
tory response from the musculoskeletal system, acting
through mechanoreceptors in muscle and bone, as it
adapts to better cope with the increasing mechanical
load [19]. Adipokines also act as regulatory messengers
between adipocytes in fat deposits, muscle [20] and bone
[21,22]. However, with excessive accumulation of body fat,
the increased loading could exceed compensatory muscu-
loskeletal responses thereby altering the proportions of
fat, lean and bone issue. As a consequence, increases in
BMI could reflect increased weight-for-height yet mask
changes in body composition. Considering the obesity
epidemic, a more accurate indicator of body fatness is
required to better assess obesity-related health risks.
Our study has several strengths and limitations. The
major strength is that study participants were selected
at random from a clearly-defined population and this is
important when reporting prevalence estimates. Further-
more, body composition was measured using anthropomet-
ric values (weight and height) in addition to whole body
densitometry which provided a more accurate assessment
of body fat mass. In the absence of cross-calibration data
between the two densitometers, a sensitivity analysis
that restricted comparisons for men scanned on one
densitometer alone showed similar patterns to the full
dataset. However, we cannot exclude the possibility of
differences between the two machines. We acknowledge,
however, that DXA measurements may be obscured by
increasing levels of body fat. Lastly, our data relate to
an essentially white population and the findings may
not be pertinent to other ethnicities.
Conclusions
We report that the prevalence of obesity using a BMI
threshold may underestimate the true extent of obesity
in the white population, particularly among young and
elderly men. We also report that for both sexes, the
prevalence of underweight using a BMI threshold may
underestimate the true extent in the population. We
suggest that optimal sex-and-age-specific thresholds beimplemented for defining underweight and obesity in
terms of body fat and recognise that such definitions will
depend on risk assessment for disease, morbidity and
mortality.
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